One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2020-136957
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 3 |
Affiliation: University Hospital Ulm, Agios Pharmaceuticals (United States), Hôpital Lyon Sud, IQVIA (United States), Centre Hospitalier Universitaire de Caen, Sorbonne Université, Hôpital Saint-Antoine, Ludwig-Maximilians-Universität München, University of Oxford, Centre Hospitalier Universitaire de Bordeaux, Hannover Medical School, Hôpital Saint-Louis, Centre Hospitalier Universitaire de Lille, Centre Hospitalier Universitaire de Toulouse, University Cancer Institute Toulouse Oncopole, Institut Gustave Roussy, Hospital Universitari i Politècnic La Fe, MSD (Canada), Centrum für Integrierte Onkologie, University Hospital Cologne, The Christie NHS Foundation Trust, Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Cáncer, Centre Hospitalier Universitaire d'Angers
Ivosidenib Improves Overall Survival Relative to Standard Therapies in Relapsed or Refractory Mutant IDH1 AML: Results from Matched Comparisons to Historical Controls
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
